M&A / Deals Sun Pharma to acquire Innovcare Lifesciences for $28.7m Pharmaceutical TechnologySun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m).Read full story pharminent June 22, 2026 (Last updated: June 22, 2026) Pharmaceutical Technology Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m). Read full story Post navigation Previous: The first 14 days: How specialty programs set patients up for successNext: Post-marketing oncology studies: Enabling faster recruitment and lower costs Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
